Department of Neurosurgery, Medical University of Innsbruck, Innsbruck, Austria.
Department of Neurosurgery, Medical University of Innsbruck, Innsbruck, Austria.
World Neurosurg. 2016 Aug;92:31-36. doi: 10.1016/j.wneu.2016.04.081. Epub 2016 May 2.
Factors determining the recurrence of chronic subdural hematomas (CSDHs) are not clear. Whether opening the so-called internal hematoma membrane is useful has not been investigated.
To investigate whether splitting the inner hematoma membrane influences the recurrence rate in patients undergoing burr-hole craniotomy for CSDH.
Fifty-two awake patients undergoing surgery for 57 CSDHs were prospectively randomized to either partial opening of the inner hematoma membrane (group A) or not (group B) after enlarged burr-hole craniotomy and hematoma evacuation. Drainage was left in situ for several days postoperatively. Groups were comparable with regard to demographic, clinical, and imaging variables. Outcome was assessed after 3-6 weeks for the combined outcome variable of reoperation or residual hematoma of one third or more of the original hematoma thickness.
Fourteen patients underwent reoperation for clinical deterioration or residual hematoma during follow-up (n = 6 in group A, 21%; n = 8 in group B, 28 %) (P = 0.537). Residual hematoma of ≥ one third not requiring surgery was present in 7 patients in group A (25%) and 10 patients in group B (36%) (P = 0.383). The overall cumulative failure rate (reoperation or hematoma thickness ≥ one third) was 13/28 (46%) in group A and 18/28 in group B (P = 0.178; relative risk, 0.722 [95% confidence interval, 0.445-1.172]; absolute risk reduction -16% [95% confidence interval, -38% to 8%]).
Opening the internal hematoma membrane does not alter the rate of patients requiring revision surgery and the number of patients showing a marked residual hematoma 6 weeks after evacuation of a CSDH.
慢性硬脑膜下血肿(CSDH)复发的决定因素尚不清楚。是否打开所谓的血肿内膜是否有用尚未得到研究。
研究颅骨钻孔术治疗 CSDH 时切开内血肿膜是否会影响复发率。
前瞻性随机选择 52 例清醒患者,行颅骨钻孔术和血肿清除术。术后数天保留引流管。两组在人口统计学、临床和影像学变量方面具有可比性。术后 3-6 周评估综合结果变量(再次手术或残留血肿为原始血肿厚度的三分之一或更多)。
14 例患者在随访期间因临床恶化或残留血肿而行再次手术(A 组 n=6,21%;B 组 n=8,28%)(P=0.537)。A 组 7 例(25%)和 B 组 10 例(36%)患者存在无需手术的残留血肿≥三分之一(P=0.383)。A 组累积失败率(再次手术或血肿厚度≥三分之一)为 13/28(46%),B 组为 18/28(P=0.178;相对风险,0.722[95%置信区间,0.445-1.172];绝对风险降低 16%[95%置信区间,-38%至 8%])。
切开血肿内膜不会改变需要再次手术的患者比例,也不会改变 CSDH 清除后 6 周时明显残留血肿的患者数量。